Statistics for Long‐term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open‐label extension study
Total visits
| views | |
|---|---|
| Long‐term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open‐label extension study | 38 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Trinka-2020-Longterm-efficacy-and-safety-of-esl.pdf(legacy) | 57 |
| Trinka-2020-Longterm-efficacy-and-safety-of-esl.pdf | 6 |
Top country views
| views | |
|---|---|
| United States | 19 |
| China | 8 |
| Germany | 2 |
| Singapore | 2 |
| Vietnam | 2 |
| Argentina | 1 |
| Australia | 1 |
| United Kingdom | 1 |
| India | 1 |